An update of the incidence of fulminant hepatitis due to viral agents during pregnancy

Fulminant hepatitis in pregnant women is one of the major public health issues and remains a challenging clinical problem with extremely high maternal and fetal morbidity and mortality, which, in parallel, viral factors are the most common cause of hepatic disorders and dysfunction during pregnancy...

Descripción completa

Detalles Bibliográficos
Autor principal: Seifoleslami, Mehri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376349/
https://www.ncbi.nlm.nih.gov/pubmed/30792915
http://dx.doi.org/10.1556/1646.10.2018.40
_version_ 1783395534123302912
author Seifoleslami, Mehri
author_facet Seifoleslami, Mehri
author_sort Seifoleslami, Mehri
collection PubMed
description Fulminant hepatitis in pregnant women is one of the major public health issues and remains a challenging clinical problem with extremely high maternal and fetal morbidity and mortality, which, in parallel, viral factors are the most common cause of hepatic disorders and dysfunction during pregnancy that may lead to fulminant hepatic with a fast progression. Therefore, this review helps to inform clinicians about the current status of the incidence of fulminant hepatitis due to viral agents during pregnancy.
format Online
Article
Text
id pubmed-6376349
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Akadémiai Kiadó
record_format MEDLINE/PubMed
spelling pubmed-63763492019-02-21 An update of the incidence of fulminant hepatitis due to viral agents during pregnancy Seifoleslami, Mehri Interv Med Appl Sci Review Fulminant hepatitis in pregnant women is one of the major public health issues and remains a challenging clinical problem with extremely high maternal and fetal morbidity and mortality, which, in parallel, viral factors are the most common cause of hepatic disorders and dysfunction during pregnancy that may lead to fulminant hepatic with a fast progression. Therefore, this review helps to inform clinicians about the current status of the incidence of fulminant hepatitis due to viral agents during pregnancy. Akadémiai Kiadó 2018-09-26 2018-12 /pmc/articles/PMC6376349/ /pubmed/30792915 http://dx.doi.org/10.1556/1646.10.2018.40 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.
spellingShingle Review
Seifoleslami, Mehri
An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title_full An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title_fullStr An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title_full_unstemmed An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title_short An update of the incidence of fulminant hepatitis due to viral agents during pregnancy
title_sort update of the incidence of fulminant hepatitis due to viral agents during pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376349/
https://www.ncbi.nlm.nih.gov/pubmed/30792915
http://dx.doi.org/10.1556/1646.10.2018.40
work_keys_str_mv AT seifoleslamimehri anupdateoftheincidenceoffulminanthepatitisduetoviralagentsduringpregnancy
AT seifoleslamimehri updateoftheincidenceoffulminanthepatitisduetoviralagentsduringpregnancy

Ejemplares similares